10 results
20-F
2020 FY
GRCL
Gracell Biotechnologies Inc
23 Apr 21
Annual report (foreign)
4:04pm
reasons or product quality issues. To address these unmet needs, we plan to advance the following lead TruUCAR-enabled preclinical programs:
GC502 … also completed dozens of engineering runs for IND preparation in our Shanghai process development center, achieving high product quality and good
424B4
GRCL
Gracell Biotechnologies Inc
8 Jan 21
Prospectus supplement with pricing info
1:42pm
of cancer patients cannot benefit from autologous CAR-T cell therapies due to medical reasons or product quality issues. To address these unmet needs, we plan … preparation in our Shanghai process development center, achieving high product quality and good production repeatability. We have produced hundreds
F-1/A
GRCL
Gracell Biotechnologies Inc
7 Jan 21
Registration statement (foreign) (amended)
7:03am
or product quality issues. To address these unmet needs, we plan to advance the following lead TruUCAR-enabled preclinical programs:
GC198. GC198 … TruUCAR. We have also completed dozens of engineering runs for IND preparation in our Shanghai process development center, achieving high product quality
F-1/A
4wmrnfsl
6 Jan 21
Registration statement (foreign) (amended)
12:00am
F-1/A
abx ubxgy30u
4 Jan 21
Registration statement (foreign) (amended)
9:30am
F-1
zl7ar5v42t4
18 Dec 20
Registration statement (foreign)
4:18pm
DRS/A
z0t66edjwln gj
24 Nov 20
Draft registration statement (amended)
12:00am
DRS
6rse6s7dng7si18lvz
19 Oct 20
Draft registration statement
12:00am
- Prev
- 1
- Next